-
Sector Analysis
Glaucoma – Global Drug Forecast and Market Analysis to 2030
The Glaucoma market size across the 7MM was valued at $2.8 billion in 2020 and is expected to achieve a CAGR of more than 1% during 2020-2030. Glaucoma is one of the leading causes of blindness worldwide, especially among elderly people. The main risk factors associated with glaucoma are age, race, and family history. People with chronic illnesses are also at a higher risk for glaucoma. The glaucoma market research report provides an overview of the risk factors, comorbidities, and...
-
Sector Analysis
Glaucoma: Epidemiology Forecast to 2030
This report provides an overview of the risk factors, comorbidities, and the global and historical trends for glaucoma in the seven major markets: (7MM: The US, France, Germany, Italy, Spain, the UK, and Japan). In the 7MM, the total prevalent cases of primary open-angle glaucoma (POAG) will be 7,289,907 cases in 2020 growing at an Annual Growth Rate (AGR) of more than 2%. It is forecasted that all markets will see an increase in the total prevalent cases of POAG...
-
Product Insights
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical trials on Eosinophilic Esophagitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Constipation Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H2, 2016" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Government & Regulation
Azerbaijan Upstream Fiscal and Regulatory Report – Stable PSA Regime Could Offer Favorable Terms for Underexplored Acreage
“Azerbaijan Upstream Fiscal and Regulatory Report - Stable PSA Regime Could Offer Favorable Terms for Underexplored Acreage”, presents the essential information relating to the terms which govern investment into Azerbaijan’s upstream oil and gas sector. The report sets out in detail the contractual framework under which firms must operate in the industry, clearly defining factors affecting profitability and quantifying the state’s take from hydrocarbon production. Considering political, economic and industry specific variables, the report also analyses future trends for Azerbaijan’s...
-
Product Insights
Irritable Bowel Syndrome Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Irritable Bowel Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Constipation Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H1, 2020" provides an overview of Constipation Clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...